Lannett Company, Inc. Gains 25.1%
Fri, Sep 16, 2022 at 07:21 PM
Lannett Company, Inc. (LCI:NYSE) shot up at $0.58, a gain of 25.1%. On Fri, Sep 16, 2022, LCI:NYSE hit a New 2-Week High of $0.58. The stock appeared on our News Catalysts scanner on Wed, Aug 31, 2022 at 08:14 AM in the 'BIOTECH' category. From Fri, Sep 02, 2022, the stock recorded 33.33% Up Days and 30.00% Green Days
About Lannett Company, Inc. (LCI:NYSE)
Lannett Co Inc develops, manufactures, packages, markets and distributes generic versions of branded pharmaceutical products. Its products include solid oral dosage forms, including oral solutions, nasal, topicals or parentarels.
Top 10 Gainers:
- Panbela Therapeutics Inc. (PBLA:NASDAQ), 53.03%
- Applied Optoelectronics, Inc. (AAOI:NASDAQ), 50.4%
- iBio, Inc. (IBIO:NYSEMKT), 49.84%
- Armata Pharmaceuticals Inc. (ARMP:NYSEMKT), 31.15%
- Axcella Health Inc. (AXLA:NASDAQ), 29.57%
- Anixa Biosciences, Inc. (ANIX:NASDAQ), 27.46%
- Lannett Company, Inc. (LCI:NYSE), 25.1%
- Integrated Media Technology Limited (IMTE:NASDAQ), 21.53%
- Innate Pharma S.A. (IPHA:NASDAQ), 20.87%
- TMC the metals company Inc. (TMC:NASDAQ), 20.19%